InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 03/27/2019 2:30:38 PM

Wednesday, March 27, 2019 2:30:38 PM

Post# of 785
News: $LPCN Lipocine Announces ABPM Labeling Study Results Consistent with Recently Approved Testosterone Replacement Therapy

SALT LAKE CITY , March 27, 2019 /PRNewswire/ --  Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced findings from the Ambulatory Blood Pressure Monitoring clinical study (NCT03868059) ("ABPM Study") ...

Got this from https://marketwirenews.com/news-releases/lipocine-announces-abpm-labeling-study-results-consistent-with-recently-approved-testosterone-replacement-therapy-7898508.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LPCN News